D. Scarpi et al. / Tetrahedron: Asymmetry 20 (2009) 340–350
347
resulting solution was refluxed for 48 h and a second portion of
KOH (1.4 g, 25 mmol) was added after 24 h. After cooling at rt,
the solvent was removed in vacuo, the residue was taken up into
water (15 mL) and the product was extracted with CHCl3 (3 ꢃ 15
mL). After filtration and evaporation of the solvent, amino alcohol
16 was obtained as a pale yellow oil (553 mg, 94%). Compound 16:
13C NMR d (ppm): 149.0 (s), 137.8 (s), 132.8 (s), 131.4 (d), 128.3
(d, 2C), 127.7 (d, 2C), 127.6 (d), 126.7 (d), 123.8 (d), 120.1 (d),
99.9 (d), 77.1 (d), 74.0 (d), 73.5 (t), 68.2 (t), 55.5 (t), 49.6 (t), 18.2
(q). MS m/z (%): 325 (M+, 7), 234 (M+ꢁBn, 94), 118 (100), 91 (93).
Anal. Calcd for C20H23NO3: C, 73.82; H, 7.12; N, 4.30. Found: C,
73.95; H, 7.46; N, 4.26.
½
a 2D4
ꢄ
¼ ꢁ52:0 (c 1.03, CHCl3). 1H NMR d (ppm): 7.40–7.30 (m, 5H),
5.40 (s, 1H), 4.61 (qAB, J 12.1 Hz, 2H), 4.24–4.10 (m, 2H), 3.99–3.84
(m, 2H), 3.24–3.12 (m, 1H), 2.88 (qAB, J 13.2 Hz, 2H), 2.66 (d, J 13.2
Hz, 1H). 13C NMR d (ppm): 137.3 (s), 128.2 (d, 2C), 127.6 (d), 127.5
(d, 2C), 100.7 (d), 77.0 (d), 74.5 (d), 73.6 (t), 67.5 (t), 49.0 (t), 45.2
(t). MS m/z (%): 144 (M+ꢁBn, 38), 91 (100). Anal. Calcd for
C13H17NO3ꢀH2O: C, 64.71; H, 7.38; N, 5.80. Found: C, 64.24; H,
7.37; N, 5.90.
4.2.4. (1S,5S,7R)-7-Benzyloxymethyl-3-methanesulfonyl-6,8-
dioxa-3-azabicyclo[3.2.1]octane 17e
At first, Et3N (62
lL, 0.44 mmol) and CH3SO2Cl (50 mg, 0.44
mmol) were added to a solution of 16 (80 mg, 0.34 mmol) in anhy-
drous DCM (7 mL), stirred at room temperature and under nitrogen
atmosphere. The reaction was monitored by TLC (eluent: DCM–
MeOH, 20:1) and, after 28 h, DCM was added (8 mL) and the organ-
ic phase was washed with 1 M HCl (10 mL), satd NaHCO3 (10 mL),
water (2 ꢃ 10 mL), brine (10 mL) and finally dried over Na2SO4.
After filtration and evaporation of the solvent, the crude was puri-
fied by FCC (eluent: DCM–MeOH, 60:1; Rf = 0.65), affording pure
17e as a white solid (86 mg, 81%). Compound 17e: mp 90–91 °C.
4.2. General procedure for arylation with arylboronic acids
To a solution of amino alcohol 16 (118 mg, 0.5 mmol) in anhy-
drous DCM (3.2 mL) were added the desired aryl boronic acid (1.0
mmol), anhydrous Cu(AcO)2 (0.5 mmol) and Et3N (1.0 mmol). The
resulting blue suspension was stirred under an oxygen atmosphere
(balloon) at room temperature for 5 h. The dark green suspension
was then diluted with DCM (12 mL) and washed with 10% aq
NH4OH (3 ꢃ 10 mL). The aqueous phases were extracted once with
DCM (10 mL) and the combined organic layers were washed with
water (2 ꢃ 10 mL), brine (15 mL) and dried over Na2SO4. After fil-
tration and evaporation of the solvent, the crude was straightly
purified by FCC (eluent: EtOAc–petroleum ether, 1:7 + 0.5% Et3N)
to afford pure N-aryl compounds 17b–d.
½
a 2D6
ꢄ
¼ ꢁ47:4 (c 0.74, CHCl3). 1H NMR d (ppm): 7.36–7.28 (m,
5H), 5.59 (s, 1H), 4.59 (s, 2H), 4.51–4.45 (m, 1H), 4.30–4.21 (m,
1H), 4.03–3.83 (m, 2H), 3.69 (d, J 11.9 Hz, 1H), 3.52 (d, J 11.4 Hz,
1H), 3.16 (dd, J 12.1, 2.9 Hz, 1H), 2.92 (d, J 11.4 Hz, 1H), 2.74 (s,
3H). 13C NMR d (ppm): 137.7 (s), 128.4 (d, 2C), 127.9 (d, 2C),
127.8 (d), 98.3 (d), 76.3 (d), 73.8 (t), 72.5 (d), 68.0 (t), 49.1 (t),
44.7 (t), 34.5 (q). MS m/z (%): 313 (M+, 1), 234 (M+ꢁMs, 8), 128
(8), 91 (100). Anal. Calcd for C14H19NO5S: C, 53.66; H, 6.11; N,
4.47. Found: C, 53.95; H, 6.46; N, 4.86.
4.2.5. (1S,5S,7R)-7-Benzyloxymethyl-3-(toluene-4-sulfonyl)-
6,8-dioxa-3-azabicyclo[3.2.1]octane 17f
4.2.1. (1S,5S,7R)-7-Benzyloxymethyl-3-phenyl-6,8-dioxa-3-
azabicyclo[3.2.1]octane 17b
Prepared as reported for 17e. Starting from 16 (89 mg, 0.38
mmol) and TsCl (95 mg, 0.50 mmol) and obtaining, after purifica-
tion by FCC (eluent: EtOAc–petroleum ether, 1:1; Rf = 0.26), pure
17f (100 mg, 71%) as a white solid. Compound 17f: mp 145–146
White solid (50%). Rf = 0.38. mp 64–65 °C. ½a D23
¼ ꢁ59:1 (c 0.75,
ꢄ
CHCl3). 1H NMR d (ppm): 7.38–7.30 (m, 5H), 7.28–7.22 (m, 2H),
6.82 (t, J 7.0 Hz, 1H), 6.69–6.64 (m, 2H), 5.65 (s, 1H), 4.59–4.55
(m, 1H), 4.53 (qAB, J 12.1 Hz, 2H), 4.31–4.22 (m, 1H), 3.91–3.83
(m, 1H), 3.75–3.66 (m, 1H), 3.54–3.47 (m, 2H), 3.15 (dd, J 12.5,
2.9 Hz, 1H), 2.94 (dd, J 11.7, 1.5 Hz, 1H). 13C NMR d (ppm): 149.1
(s), 137.8 (s), 129.2 (d, 3C), 128.4 (d, 2C), 127.8 (d, 2C), 118.3 (d),
112.5 (d, 2C), 99.1 (d), 75.7 (d), 73.6 (t), 73.1 (d), 68.4 (t), 51.2
(t), 46.0 (t). MS m/z (%): 311 (M+, 7), 220 (M+ꢁBn, 46), 105 (100),
91 (71). Anal. Calcd for C19H21NO3: C, 73.29; H, 6.80; N, 4.50.
Found: C, 73.19; H, 6.98; N, 4.69.
°C. ½a 2D6
ꢄ
¼ þ4:6 (c 0.85, CHCl3). 1H NMR d (ppm): 7.63 (d, J 8.4
Hz, 2H), 7.38–7.27 (m, 7H), 5.51 (s, 1H), 4.60 (s, 2H), 4.41–4.38
(m, 1H), 4.27–4.18 (m, 1H), 4.08–3.89 (m, 2H), 3.68 (d, J 12.1 Hz,
1H), 3.57 (d, J 11.0 Hz, 1H), 2.79 (dd, J 11.7, 2.2 Hz, 1H), 2.58 (d, J
11.4 Hz, 1H), 2.44 (s, 3H). 13C NMR d (ppm): 143.8 (s), 137.7 (s),
132.1 (s), 129.6 (d, 2C), 128.3 (d, 2C), 127.7 (d, 2C), 127.6 (d),
127.4 (d, 2C), 98.3 (d), 76.2 (d), 73.7 (t), 72.4 (d), 68.1 (t), 49.2
(t), 44.8 (t), 21.6 (q). MS m/z (%): 389 (M+, 0.4), 298 (M+ꢁBn, 12),
234 (22), 128 (21), 91 (100). Anal. Calcd for C20H23NO5S: C,
61.68; H, 5.95; N, 3.60. Found: C, 61.46; H, 5.91; N, 3.50.
4.2.2. (1S,5S,7R)-7-Benzyloxymethyl-3-(4-methoxyphenyl)-6,8-
dioxa-3-azabicyclo[3.2.1]octane 17c
Pale pink solid (43%). Rf = 0.34. mp 91–92 °C. ½a D23
ꢄ
¼ ꢁ61:5 (c
4.2.6. (1S,5S,7R)-7-Benzyloxymethyl-3-(2-fluoroethyl)-6,8-
dioxa-3-azabicyclo[3.2.1]octane 17g
0.92, CHCl3). 1H NMR d (ppm): 7.39–7.31 (m, 5H), 6.92–6.82 (m,
2H), 6.68–6.60 (m, 2H), 5.65 (s, 1H), 4.57 (qAB, J 12.1 Hz, 2H),
4.58–4.53 (m, 1H), 4.35–4.25 (m, 1H), 3.98–3.90 (m, 1H), 3.83–
3.75 (m, 1H), 3.79 (s, 3H), 3.44 (d, J 11.4 Hz, 2H), 3.12 (dd, J 12.1,
2.6 Hz, 1H), 2.90 (dd, J 11.4, 1.1 Hz, 1H). 13C NMR d (ppm): 152.5
(s), 143.3 (s), 137.7 (s), 128.2 (d, 2C), 127.7 (d, 2C), 127.6 (d),
114.5 (d, 2C), 114.0 (d, 2C), 99.1 (d), 75.8 (d), 73.5 (t), 73.1 (d),
68.2 (t), 55.6 (q), 52.0 (t), 47.0 (t). MS m/z (%): 341 (M+, 41), 250
(M+ꢁBn, 64), 135 (100), 120 (32), 91 (39). Anal. Calcd for
C20H23NO4: C, 70.36; H, 6.79; N, 4.10. Found: C, 70.55; H, 6.73; N,
4.14.
In a 5-mL flask equipped with a reflux condenser and magnetic
stirrer were placed amino alcohol 16 (124 mg, 0.53 mmol), 2-flu-
oroethyltosylate (127 mg, 0.58 mmol), NaHCO3 (89 mg, 1.06
mmol) and dry DMF (1.6 mL). The mixture was heated at 80 °C
for 19 h and, after cooling, aqueous NH4OH 10% (16 mL) was
added and the product was extracted with Et2O (4 ꢃ 10 mL).
The combined organic phases were washed with water (3 ꢃ 10
mL) and dried over Na2SO4. After filtration and evaporation of
the solvent, the thus obtained crude was purified by FCC (eluent:
EtOAc–petroleum ether, 1:6 + 0.5% Et3N; Rf = 0.29) to afford pure
17g as
a
colourless oil (104 mg, 70%). Compound 17g:
4.2.3. (1S,5S,7R)-7-Benzyloxymethyl-3-o-tolyl-6,8-dioxa-3-azabic-
½
a 2D3
ꢄ
¼ ꢁ68:4 (c 1.38, CHCl3). 1H NMR d (ppm): 7.37–7.27 (m,
yclo[3.2.1]octane 17d
5H), 5.45 (s, 1H), 4.58 (qAB, J 11.7 Hz, 2H), 4.56–4.50 (m, 1H),
4.36–4.28 (m, 2H), 4.27–4.18 (m, 1H), 4.12–4.04 (m, 1H), 3.98–
3.90 (m, 1H), 2.86–2.80 (m, 2H), 2.72–2.50 (m, 3H), 2.39 (d, J
11.0 Hz, 1H). 13C NMR d (ppm): 137.9 (s), 128.2 (d, 2C), 127.7
(d, 2C), 127.5 (d), 99.6 (d), 81.7 (dt, JCF 167.9 Hz), 76.6 (d), 73.7
(d), 73.4 (t), 68.0 (t), 56.7 (dt, JCF 19.8 Hz), 56.7 (t), 52.0 (t). MS
Yellow oil (10%). Rf = 0.48. ½a D26
ꢄ
¼ ꢁ123:7 (c 0.5, CHCl3). 1H NMR
d (ppm): 7.33–7.02 (m, 9H), 5.56 (d, J 1.5 Hz, 1H), 4.57 (qAB, J 11.7
Hz, 2H), 4.49–4.45 (m, 1H), 4.40–4.31 (m, 1H), 4.22–4.14 (m, 1H),
4.01–3.94 (m, 1H), 3.58 (dd, J 12.1, 2.2 Hz, 1H), 3.15 (d, J 11.4 Hz,
1H), 2.88 (d, J 12.5 Hz, 1H), 2.68 (d, J 11.7 Hz, 1H), 2.27 (s, 3H).